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In Lyme disease spirochetes, the ospC gene encodes a 22.7-kDa protein referred to as either the pC or the
OspC protein. Using a variety of electrophoretic approaches followed by Southern blotting and probing with
oligonucleotide probes, we mapped the ospC gene to a circular 26-kb plasmid. The ospC gene represents the
first gene to be mapped to a circular plasmid in Lyme disease spirochetes. The occurrence of this gene in isolates
belonging to each of the three Lyme disease-associated species, Borrelia burgdorfieri, Borrelia garinii, and the
VS461 group, was evaluated. The ospC gene was found to occur in all 21 isolates tested from each of the three
species. Differential hybridization with a series of ospC probes in both Northern (RNA) and Southern blot
analyses demonstrated that there is sequence variability in the ospC gene among isolates. While the gene was
found to be present in all isolates, not all actively transcribed the gene. Transcriptional start site analyses
suggest that the gene may be under the control of multiple promoters that are highly similar in nucleotide
sequence.

The organization of the genetic material among members
of the genus Borrelia is unusual among eubacteria in that the
genetic material is distributed between a linear chromosome
and a series of both linear and circular plasmids (4, 5, 10).
Although variable, Borrelia plasmids account for a significant fraction of the total genetic material. In Lyme disease
borreliae, all genes mapped to date have been found to reside
on either the 1,000-kb linear chromosome (12, 28) or, in the
case of the ospAB operon, on a linear plasmid (5, 6, 8) that
ranges in size from approximately 49 to 59 kb (4, 5, 13, 23).
In general, the coding capacity of the plasmids remains
largely undefined. It seems likely that in addition to ospAB,
other genes will also be mapped to plasmids.
Recently, a third outer surface protein (OspC) in Lyme
disease spirochetes was identified, and its gene was sequenced (11). The physiological role or pathological significance of OspC has not yet been defined. Although somewhat
variable among isolates, the molecular mass of OspC is
approximately 22.7 kDa. OspC appears distinct from the
22-kDa proteins described by Luft et al. (14) and Simpson et
al. (26). The level of expression of OspC has also been found
to vary among isolates. Wilske et al. reported that OspC is
expressed as a major protein in approximately 45% of
European isolates and only rarely in North American isolates (31). For the three spirochete species, Borrelia burgdorfeni, Borrelia garinii, and group VS461, known to be
associated with Lyme disease (2, 15-17, 19, 29), the presence, degree of conservation, and map location of the ospC
gene have not yet been addressed.
In this study, we have mapped the location of the ospC
gene, determined its transcriptional start site(s), and compared the expression of the gene among isolates of Lyme
disease spirochetes. The results presented here demonstrate
that the ospC gene is carried on a 26-kb circular plasmid. The
ospC gene represents the first Borrelia gene to be mapped to
a circular plasmid. Transcriptional start site analyses have
revealed that the control region of the gene is similar among
*

isolates of Lyme disease spirochetes and that the gene may
be under the control of multiple promoters. Northern (RNA)
blot analysis has also demonstrated that the transcriptional
expression of the ospC gene varies among isolates.

MATERMILS AND METHODS
Cultivation of Borrelia isolates. The isolates investigated in
this study are described in Table 1. All isolates were previously identified to the species level by 16S rRNA sequence
analysis (1, 16, 17), through the use of 16S rRNA-directed
species-specific oligonucleotide probes (19) or polymerase
chain reaction primer sets (15), by DNA-DNA hybridization
(2, 20), or by multilocus enzyme electrophoresis (9). The
species nomenclature used in this paper is that proposed by
Baranton et al. (2). Bacterial isolates were cultivated in
BSKII medium at 34°C (3), harvested by centrifugation, and
washed twice with phosphate-buffered saline prior to use in
subsequent experiments.
Southern blot analysis of the ospC gene. DNA was isolated
as previously described (7). Whole-cell DNA was fractionated by electrophoresis in 0.35% agarose gels with TAE
buffer (40 mM Tris-acetate, 1 mM EDTA [pH 8.5]) at 0.4
V/cm for 48 h. Fractionated DNA was transferred to GeneScreen membranes by use of the VacuGene vacuum blot
system as instructed by the manufacturer (Pharmacia-LKB).
The transferred DNA was fixed to the membranes by UV
cross-linking with a Stratalinker (Stratagene) as instructed
by the manufacturer. ospC hybridization probes were synthesized on the basis of the ospC sequence previously
presented for the Lyme disease isolate PKo (11). Both Adam
et al. (1) and Wallich et al. (28) have identified this isolate as
belonging to the VS461 group of Lyme disease spirochetes.
Oligonucleotide probe sequences are presented in Table 2.
All sequences

given

in this paper

are

listed 5'

-*

3'.

Oligo-

nucleotide probes were 5' end labeled with [_y-32P]ATP by
use of polynucleotide kinase by standard methods. Radiolabeled probes were purified from unincorporated label by
passage through G25 spin columns as instructed by the
manufacturer (Boehringer Mannheim). The blots were pre-

Corresponding author.
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TABLE 1. Borrelia isolates used in this study
Isolates

Geographic

Biological sourcea

Borrelia burgdorferi
25015
Illinois 1
1352
20004
IP2A
CA12
3028

New York
Illinois
Texas
France
France
California
Texas

Amblyomma americanum
Icodes ricinus

Borrelia ganrnii
G25, VS102
G1
R-IP90
20047
N34

Sweden
Germany
Russia
France
Germany

Ixodes ricinus
Human CSF
Ixodes persulcatus
Ixodes ricinus
Ixodes ricinus

VS461 group
U01, ECM1, UM01
R-IP21, R-IP3
VS461
B023
Ji

Sweden
Russia
Sweden
Germany
Japan

EM (human)
Ixodes persulcatus
Ixodes ricinus

a

Ixodes dammini
Mouse

Human CSF

Icodes pacificus
Human pus

Human skin

Ixodes persulcatus

CSF, cerebrospinal fluid; EM, erythema migrans.

hybridized in hybridization buffer (16) for 1 to 4 h at 370C.
After prehybridization, the buffer was removed and radioactive probes at 10 ng/ml in fresh hybridization buffer were
added to the hybridization bottles. Hybridization was conducted for 16 to 24 h at 370C. The blots were washed twice
in 2x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium
citrate)-O.1% sodium dodecyl sulfate (SDS) at 370C (10 min
each) and once for 1 h in O.lx SSC-0.1% SDS at 370C,
wrapped in cellophane, and exposed to Kodak XAR5 film at
-700C with intensifying screens.
Two-dimensional agarose gel electrophoresis. For determination of the conformation of the DNA molecule carrying
the ospC gene, two-dimensional gel electrophoresis was
performed (21, 22). DNA from isolates R-IP21 and VS461
was electrophoresed in 0.35% agarose gels in the first
dimension for 18 h at 0.4 V/cm with TAE buffer. The gels
were then equilibrated in second-dimension running buffer
(15 pM chloroquine in TAE buffer) by soaking for S h. After
the gels were rotated 900 relative to the direction of electrophoresis in the first dimension, electrophoresis was performed for 18 h at 0.4 V/cm. Prior to ethidium bromide
staining, the gels were soaked in H20 for several hours to
remove the chloroquine. Fractionated DNA was transferred
TABLE 2. Oligonucleotide hybridization probe or
primer sequences
Probe or

primer

pC13
pC52
pC67
pC609
nc2O

Sequence (5' 3')'

GTC-ATT-AAT-ATC-GCA-CTT-AAT-G
CCC-TGA-ATT-ATT-ACA-AGA
TGC-AGA-ATC-CCC-ACC-TTT-CCC
TGG-ACT-TTC-TGC-TAC-AAC-AGG
ATG-AAT-TAT-AGT-CCA-ACA-AT

Target

regionb
13 to 35
52 to 66
67 to 87
609 to 629
-40 to -20

a All probes or primers complement the coding (plus) strand.
The numbers given are relative to the translational start codon of the ospC
sequence previously presented for VS461 group isolate PKo (11).
b
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to GeneScreen membranes for hybridization analysis with
ospC oligonucleotide probes as described above.
Transcriptional start site and Northern blot analyses. Total
cellular RNA was isolated as previously described (25). All
reagents were either prepared with diethylpyrocarbonatetreated H20 or treated directly with diethylpyrocarbonate by
standard methods. The transcriptional start site(s) for the
ospC gene was determined by reverse transcriptase primer
extension. Fifteen micrograms of total cellular RNA was
incubated with 2 pmol of 5'-end-labeled primer pC13, pC52,
pC67, or nc2O in 10 RI1 of annealing buffer (100 mM KCI, S
mM Tris-HCI [pH 7.5]) at 850C for 4 min and then at 30'C for
4 to 6 h. Fifteen microliters of reverse transcription mixture
(0.9 mM each dATP, dTTP, dCTP, and dGTP; 83 mM
Tris-HCI [pH 8.3]; 8 mM dithiothreitol; 8 mM MgCl2; 83 pug
of bovine serum albumin per ml) and 50 U of avian myeloblastosis virus reverse transcriptase were added, and the
reaction mixtures were incubated for 1.5 h at 47°C. For
digestion of the RNA, 1 ,u1 of 0.5 M EDTA and 1 ,u1 of RNase
(0.5 Rg/pRl) were added and the mixture was incubated for 0.5
h at 37°C. One volume of 2.5 M ammonium acetate was
added to each tube, and each was extracted with an equal
volume of phenol-chloroform-isoamyl alcohol. The extension products were precipitated with ethanol, washed with
70% ethanol, vacuum dried, resuspended in 10 ,u1 of formamide loading buffer (50% formamide, 10 mM EDTA, 0.025%
bromophenol blue, 0.025% xylene cyanol), heated at 85°C
for S min, and loaded onto 7% polyacrylamide sequencing
gels (8 M urea, 83 mM Tris-borate, 1 mM EDTA [pH 8.0]).
The approximate sizes of the extension products were determined by use of a DNA sequencing ladder. After electrophoresis, the gels were transferred directly to 3MM paper
(Whatman) and exposed to Kodak XAR5 film for 3 h.
Northern blot analysis was used to assess the expression
of the ospC gene and to determine the nucleotide length of
the transcript. Fifteen micrograms of RNA sample was
electrophoresed through 1.2% agarose-formaldehyde gels as
previously described (27). The RNA was transferred to
GeneScreen membranes and hybridized as described above
for the Southern blot analysis. The length of the ospC
transcript was determined by use of an NA2 nucleic acid
analyzer as instructed by the manufacturer (Bethesda Research Laboratories).

RESULTS AND DISCUSSION
Mapping of the ospC gene to a circular plasmid. In this
study, we sought to map the ospC locus in a variety of
isolates of each of the three Lyme disease-associated spirochete species (2, 9, 15-17, 19, 20, 29). Total DNA from the
isolates listed in Table 1 was isolated and fractionated in
0.35% agarose gels. After Southern transfer, the blots were
probed with an ospC oligonucleotide probe (pC13). Two or
three hybridization bands that differed in intensity and
relative ratio among isolates were observed. The ethidium
bromide-stained gel and the corresponding Southern blot of
representative isolates are presented in Fig. 1. The detection
of more than one band suggested that the probe was either
hybridizing with an ospC gene carried on multiple DNA
species or cross-hybridizing with non-ospC but closely related sequences. To differentiate between these possibilities,
we used a second probe (pC609), which complements a
region in the 3' end of the ospC gene, to rescreen some of the
blots. This probe hybridized with the same bands as the
pC13 probe. A third probe (pC67) also yielded identical
hybridization results. Both the pC67 and the pC609 probes,
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FIG. 1. Agarose gel fractionation of Lyme disease spirochete DNA and Southernblot analysis of the ospC gene.TotalIDNA isolated from
the three Lyme disease-associated organisms was fractionated in 0.35% agarose gels, stained with ethidium bromide (A), transferred to
GeneScreen membranes, and probed with the pCl3 probe (B) as described in the text. DNA from the following respective isolates was
analyzed: lanes 1 and 2, B. garinii VS102 and R-1P90; lanes 3 and 4, B. burgdorferi 20004 and IP2A; and lanes 5 to 9, VS461 group isolates
R-IP21, VS461, R-IP3, ECM1, and UMOL. DNA molecular size markers are given in kilobases. The three plasmid forms are indicated by I
(supercoiled), II (relaxed), and III (linearized).

however, did not hybridize with the ospC gene in all isolates,
suggesting sequence variability in this gene (see below).
Nonetheless, the use of multiple probes, all of which hybridized with the same DNA bands, demonstrates that the
multiple hybridization signals observed were due to the
detection of multiple ospC-carrying DNA molecules.
The detection of multiple hybridizing bands and their
relative migration rates in agarose gels suggested that the
gene may be carried on a circular plasmid. Circular plasmids
can be found in three distinct conformational states. Form I
is the supercoiled form. Form II consists of relaxed molecules that comigrate with supercoiled plasmids that have
been nicked. Form III represents plasmids that have been
linearized by a double-strand break. The hybridization pattern suggested a circular plasmid of 26 kb, with the supercoiled form (I) migrating with an apparent size of 12 kb and
the nicked or relaxed form (II) migrating with an apparent
size of 44 kb (Fig. 1B). Furthermore, upon restriction of the
DNA from several isolates with EcoRV, Southern blotting,
and probing with the pC67 probe, only one hybridization
band was observed (data not shown). These results further
support the idea that one copy of the ospC gene was present
and being carried on different conformational forms of the
same plasmid.
While the detection of multiple hybridizing bands in
undigested DNA preparations is highly suggestive of a
circular plasmid, we further addressed this question by using
two-dimensional gel electrophoresis. Linear and circular
plasmids, which cannot be distinguished from each other by
conventional agarose gel electrophoresis, can be conclusively differentiated via this approach. For these analyses,
new DNA preparations were gently isolated (i.e., vortexing
and pipetting were minimized during isolation) from VS461
group isolates R-IP21 and VS461 to reduce shear damage to
the circular plasmids in the DNA preparations. After stan-

dard electrophoresis of the DNA in the first dimension, the
gels were equilibrated in chloroquine. Chloroquine intercalates into the DNA, causing an unwinding of the double
helix. The electrophoretic mobility of linear molecules is not
significantly affected by chloroquine treatment. These molecules migrate along an apparent diagonal axis in twodimensional chloroquine gels. However, the electrophoretic
mobility of negatively supercoiled plasmids is retarded by
chloroquine treatment and, as a result, these plasmids migrate off the diagonal axis during electrophoresis in the
second dimension (22). Three DNA species were found in
ethidium bromide-stained gels to migrate off the diagonal
axis, indicating that these molecules were covalently closed
and negatively supercoiled (Fig. 2A). The gels were then
blotted and subjected to Southern blot analysis with the
pC67 hybridization probe. A hybridization signal was detected associated with one of the molecules running off the
diagonal axis (Fig. 2B), demonstrating that the ospC gene is
carried on a single negatively supercoiled plasmid. In contrast to the results of the Southern blot analysis described
above, only one band was found to hybridize with the probe.
Hence, the elimination of vortexing from the DNA isolation
procedure significantly reduced shearing of the circular
plasmids and, as a result, only the supercoiled form of the
ospC-carrying plasmid was observed. The size of the circular plasmid was obtained by measuring the linearized form
(Fig. 1) and found to be 26 kb.
Occurrence and conservation of the ospC gene in Lyme
disease spirochetes. Wilske et al. have reported that OspC is
expressed in 45% of European isolates and only rarely in
North American isolates (31). To evaluate the occurrence of
the ospC gene, we performed Southern blotting of undigested whole-cell DNA from a variety of isolates of the three
spirochete species associated with Lyme disease. The results obtained with representative isolates are presented in
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FIG. 2. Two-dimensional gel electrophoresis of DNA from Lyme disease isolate VS461 and Southern blot analysis with the pC67 probe.
Electrophoresis of DNA from isolate VS461 was conducted in the first dimension in 0.35% agarose gels. The gels were then equilibrated in
15 puM chloroquine, rotated 90°, and electrophoresed in the second dimension as described in the text. The DNA was visualized by ethidium
bromide staining (A) and then transferred to GeneScreen membranes for Southern blotting as described in the text with the radiolabeled pC67
oligonucleotide probe (B). In both panels, the position of the loading well is indicated by a circle, and that of the 26-kb plasmid is indicated
by an arrow. The direction of migration in each dimension is also given. DNA molecular size markers are given in kilobases.

Fig. 1. Detection of the ospC gene in a given isolate was
found to be dependent on the probe used. While the pC609
probe was found to exhibit differential hybridization with
different isolates, this probe was not used to screen all
isolates and hence will not be discussed further. Most B.
burgdorferi isolates and B. garinii G1 and R-IP90 were
hybridization negative with the pC67 probe but hybridization
positive with the pC13 probe. B. burgdorfen 25015 and
Illinois 1 were exceptions in that they hybridized with both
the pC67 and the pC13 probes. We have demonstrated the
peripheral relationship of these isolates to others of B.
burgdorferi via 16S rRNA sequence analysis (15). In contrast to B. gannii R-IP90 and G1, VS461 group isolates and
B. gannii G25, 20047, and VS102 were hybridization positive
with both the pC13 and the pC67 probes. Hence, while the
phenotypic expression of the ospC gene appears most pronounced in European isolates, the ospC gene itself is present
in all three Lyme disease-associated spirochete species.
Furthermore, it consistently maps to an approximately 26-kb
circular plasmid in all isolates tested. The variability in
hybridization among isolates indicates that the ospC gene
sequence may be somewhat variable. A similar variability
has been noted for outer surface protein genes ospA and
ospB (7, 13, 18, 30).
Northern blot analysis of the ospC transcript. To determine
in which isolates the ospC gene was being transcriptionally
expressed, we performed Northern blot analysis with the
pC13 and pC67 hybridization probes. Consistent with the
Southern blot analysis discussed above, the detection of the
ospC transcript in a given isolate was dependent on the
probe used. ospC transcript size was constant among isolates, being approximately 700 to 730 nucleotides (Fig. 3).
The ospC coding sequence alone (excluding 5' and 3' noncoding sequences) would generate a 636-base transcript.
While the ospC gene was detected by Southern blot analysis
in all isolates with either the pC13 or the pC67 probe, we did
not detect the transcript in several isolates by Northern blot
analysis with these same probes. B. burgdorferi CA12 and

1352, B. garinii N34, and VS461 group isolates J1, R-IP21,
and UM01 were all found to carry the ospC gene but not to
express it under the growth conditions used in these experiments. The rRNA bands in the hybridization-negative preparations were found to show good integrity via ethidium
bromide staining, providing indirect evidence that the lack of
hybridization was not the result of template degradation.
Furthermore, using these same RNA preparations, we were
able to detect the ospAB transcript. Factors associated with
the transcriptional activation of the ospC gene have not yet
been defined. In addition, several VS461 group isolates that
produced the ospC transcript did not exhibit detectable
amounts of OspC protein, as determined by inspection of
Coomassie-stained sodium dodecyl sulfate-polyacrylamide
gel electrophoresis whole-cell protein profiles (data not
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FIG. 3. Detection of the ospC transcript by Northern blot analysis. Fifteen micrograms of total cellular RNA was fractionated in
1.2% agarose-formaldehyde gels, vacuum blotted onto GeneScreen
membranes, and hybridized with the pCl3 probe as described in the
text. The species designation for each isolate is indicated by the

prefixes Bb for B. burgdorferi, Bg for B. garinii, and (VS) for VS461
group isolates. The positions of 23S and 16S rRNAs (approximately
2,900 and 1,540 bases, respectively) are indicated.
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(P1, P2, and P3) inferred from reverse transcriptase primer extension experiments are indicated by capital letters, and -10 TATA
box sequences are underlined. Nucleotide position numbering is
with respect to the first base (+1) of the translational start codon
indicated by italics. Transcriptional start sites are indicated by an
asterisk over the appropriate nucleotide. The sequence presented is
from VS461 group isolate PKo (11).
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FIG. 4. Transcriptional start site analyses by reverse transcriptase primer extension. All methods were as described in the
text. The pC52 primer was used in the primer extension reactions.
The lanes (left to right) contain the extension products obtained
when total RNAs (15 pLg) from B. burgdorferi 3028, B. garnii
VS102, and VS461 group isolate ECM1, respectively, were used as
templates. The numbers on the left indicate the approximate number
of bases 5' of the translational start codon for each major primer
extension termination site, as determined by electrophoresis of a
sequencing ladder in adjacent lanes.

shown). OspC expression in these isolates may be subject to
some form of translational control. Alternatively, there may
be mutations in the gene that result in premature translational termination. It has been demonstrated that the phenotypic expression of the ospA and ospB genes in some isolates
can be influenced by the number of in vitro passages (24).
While in this study we did not systematically monitor OspC
expression over a large number of passages in a given
isolate, isolates of both high and low passage numbers were
used. No correlation between passage number and OspC
expression was observed.
Transcriptional start site analyses of the ospC gene. To
identify the putative promoter(s) of the ospC gene, we
performed transcriptional start site analyses by using reverse
transcriptase primer extension. By using two independent
primers (pC13 and pC52), the same primer extension termination sites were observed in all isolates which had been by
Northern blot analysis to be expressing the ospC gene. The
major termination sites mapped approximately 18 to 22
nucleotides upstream from the translational start codon. The
results obtained with a representative isolate of each of the
three Lyme disease-associated species and the pC52 primer
are presented in Fig. 4. An appropriately spaced consensus
promoter sequence (5'-TTG-AAA-A) that we refer to as P1
and a consensus TATA box sequence (5'-TATTAA) were
identified upstream (on the basis of the ospC sequence for
isolate PKo) (Fig. 5). Hence, the transcripts derived from the
use of promoter P1 possess a 5'-untranslated leader sequence of approximately 20 nucleotides, with the T residue
located 20 bases from the translational start codon serving as
the major transcriptional start site (TS1). Using the RNA
secondary structure analysis program of Zucker (contained
in the PCGENE software package) (32), we analyzed se-

quences 5' of the translational start codon for regions of
secondary structure that could conceivably be responsible
for the termination sites observed in the primer extension
analysis. However, significant secondary structure elements
were not observed, supporting the identification of TS1 as
the major transcriptional start site.
Through a consensus promoter sequence homology
search, Fuchs et al. (11) identified a putative promoter
upstream of P1 that we refer to as P2. This sequence is not
optimally spaced to serve as the promoter for TS1. However, when both the pC13 and the pC52 primers were used,
a second transcriptional start site (TS2) was observed upstream of the TS1 site, implicating active transcription from
a promoter 5' of P1 (Fig. 4). In B. burgdorfen 3028, a minor
extension product intermediate in size in comparison with
those derived from P1 and P2 was observed. The sequence
of this product is not appropriately spaced from a consensus
promoter sequence, so this product most likely represents a
premature termination product. P2 appears appropriately
spaced from TS2 to serve as a promoter for this transcriptional start site. Visualization of the band corresponding to
TS2 required a longer exposure of the separating gel to film
(approximately 6 to 10 h) than that required for the detection
of TS1. The exposure presented in Fig. 4 was chosen since it
allowed visualization of both transcriptional start sites without overexposure of TS1. Both P1 and P2 are identical in
sequence over a 7-base stretch (5'-TTG-AAA-A) and have
appropriately spaced -10 sequences (Fig. 5). The core
sequences of P1 and P2 and their respective -10 sequences
are separated by 15 and 13 bases, respectively. While
transcriptional start sites were observed appropriately
spaced from both P1 and P2, it is possible that only the more
distal promoter, P2, was used and that the shorter transcript
was the result of an RNA processing event. While the data
presented here are suggestive of active transcription from
more than one promoter, RNA processing cannot be ruled
out.
Upon analysis of the PKo ospC sequence (11), we noted a
third potential promoter sequence (P3) upstream of and
identical to the 7-base core sequences of P1 and P2. Over a
16-base stretch, P3 exhibits 88% sequence similarity to P2.
To determine whether this putative promoter sequence was
transcriptionally active, we used a third primer (nc2O) in the
primer extension analysis. This primer complements a sequence in the ospC gene 5' of TS1. While the 5' end of this
20-base primer complements the first 6 nucleotides of transcripts derived from the expression of promoter P2, these
transcripts should not serve as a template for primer extension, since the 3' end of this primer does not hybridize.
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Hence, any extension products should be derived from
hybridization with a transcript that uses a more distal 5'
promoter. In two isolates (B. burgdorfen 3028 and B. gannii
VS102), a weak transcription start site, not previously observed when primers pC13 and pC52 were used, was detected (data not shown). Hence, promoter P3 may be used at
a low level in the transcription of the ospC gene in some
isolates. The low level of transcription from this promoter
may be a reflection of the spacing between the -35 and -10
sequences (11 bases). None of the three transcriptional start
sites described above was observed in isolate R-IP21, which
was shown not to produce the ospC transcript by Northern
blot analysis, demonstrating that the start sites detected
were not the result of spurious or nonspecific primer extension from non-ospC transcripts. The role of each promoter,
the extent to which each is used, and the factors influencing
promoter selection in vivo are currently undefined.
The ospC gene represents the first Borrelia gene to be
mapped on a circular plasmid. The plasmid is approximately
26 kb in size. On the basis of hybridization results with a
variety of oligonucleotide probes, this gene appears to
exhibit some variability in its coding sequence among the
Lyme disease isolates tested. The organization of the upstream regulatory regions, however, appears similar among
isolates with a potential multiple-promoter arrangement. The
results presented here may provide further insight into the
genetic coding capacity of the plasmids found in Lyme
disease isolates. Since the plasmids represent approximately 150 kb of genetic material, it is likely that additional
genes will be localized on plasmids and shown to encode
products that may be important in the pathobiology of Lyme
disease.
ACKNOWLEDGMENTS
We thank J. Anderson, G. Baranton, A. Barbour, S. Barthold, J.
Nelson, 0. Peter, D. Postic, J. Rawlings, P. Rosa, and T. Schwan
for providing isolates; J. Heinemann and J. Hinnebusch for helpful

discussions and critical review of the manuscript; and R. Evans and
G. Hettrick for providing the graphic work.

1.
2.

3.
4.
5.
6.
7.

8.

REFERENCES
Adam, T., G. S. Gassmann, C. Rasiah, and U. B. Gobel. 1991.
Phenotypic and genotypic analysis of Borrelia burgdorferi isolates from various sources. Infect. Immun. 59:2579-2585.
Baranton, G., D. Postic, I. Saint Girons, P. Boerlin, J.-C.
Piffaretti, M. Assous, and P. A. D. Grimont. 1992. Delineation of
Borrelia burgdorfen sensu stricto, Borrelia gannii sp. nov., and
group VS461 associated with Lyme borreliosis. Int. J. Syst.
Bacteriol. 42:378-383.
Barbour, A. G. 1984. Isolation and cultivation of Lyme disease
spirochetes. Yale J. Biol. Med. 57:521-525.
Barbour, A. G. 1988. Plasmid analysis of Borrelia burgdorferi,
the Lyme disease agent. J. Clin. Microbiol. 26:475-478.
Barbour, A. G., and C. F. Garon. 1987. Linear plasmids of the
bacterium Borrelia burgdorferi have covalently closed ends.
Science 237:409-411.
Barbour, A. G., and C. F. Garon. 1988. The genes encoding
major surface proteins of Borrelia burgdorfen are located on a
plasmid. Ann. N.Y. Acad. Sci. 539:144-153.
Barbour, A. G., R. A. Heiland, and T. R. Howe. 1985. Heterogeneity of major proteins in Lyme disease borreliae: a molecular
analysis of North American and European isolates. J. Infect.
Dis. 152:478-484.
Bergstrom, S., V. G. Bundoc, and A. G. Barbour. 1989. Molecular analysis of the linear plasmid encoded major surface
proteins, OspA and OspB, of the Lyme disease spirochaete

931

Borrelia burgdorferi. Mol. Microbiol. 3:479-486.
9. Boerlin, P., 0. Peter, A.-G. Bretz, D. Postic, G. Baranton, and
J.-C. Piffaretti. 1992. Population genetic analysis of Borrelia
burgdorfen isolates by multilocus enzyme electrophoresis. Infect. Immun. 60:1677-1683.
10. Ferdows, M. S., and A. G. Barbour. 1989. Megabase-sized linear
DNA in the bacterium Borrelia burgdorferi, the Lyme disease
agent. Proc. Natl. Acad. Sci. USA 86:5969-5973.
11. Fuchs, R., S. Jauris, F. Lottspeich, V. Preac-Mursic, B. Wilske,
and E. Soutschek. 1992. Molecular analysis and expression of a
Borrelia burgdorfen gene encoding a 22 kDa protein (pC) in
Escherichia coli. Mol. Microbiol. 6:503-509.
12. Gassman, G. S., M. Kramer, U. B. Gobel, and R. Wallich. 1989.
Nucleotide sequence of the gene encoding the Borrelia burgdorfen flagellin. Nucleic Acids Res. 17:3590.
13. Jonsson, M., L. Noppa, A. G. Barbour, and S. Bergstrom. 1992.
Heterogeneity of outer membrane proteins in Borrelia burgdorferi: comparison of osp operons of three isolates of different
geographic origins. Infect. Immun. 60:1845-1853.
14. Luft, B. J., W. Jiang, P. Munoz, R. J. Dattwyler, and P. D.
Gorevic. 1989. Biochemical and immunological characterization
of the surface proteins of Borrelia burgdorfeni. Infect. Immun.
57:3637-3645.
15. Marconi, R. T., and C. F. Garon. 1992. Development of
polymerase chain reaction primer sets for diagnosis of Lyme
disease and for species-specific identification of Lyme disease
isolates by 16S rRNA signature nucleotide analysis. J. Clin.
Microbiol. 30:2830-2834.
16. Marconi, R. T., and C. F. Garon. 1992. Phylogenetic analysis of
the genus Borrelia: a comparison of North American and
European isolates of Borrelia burgdorferi. J. Bacteriol. 174:241244.
17. Marconi, R. T., and C. F. Garon. 1992. Identification of a third
genomic group of Borrelia burgdorferi through signature nucleotide analysis and 16S rRNA sequence determination. J. Gen.
Microbiol. 138:533-536.
18. Marconi, R. T., M. E. Konkel, and C. F. Garon. Submitted for
publication.
19. Marconi, R. T., L. Lubke, W. Hauglum, and C. F. Garon.
1992. Species-specific identification of and distinction between
Borrelia burgdorferi genomic groups by using 16S rRNAdirected oligonucleotide probes. J. Clin. Microbiol. 30:628632.
20. Postic, D., C. Edlinger, C. Richaud, F. Grimont, Y. Dufresne, P.
Perolat, G. Baranton, and P. A. D. Grimont. 1990. Two genomic
species in Borrelia burgdorferi. Res. Microbiol. 141:465-475.
21. Pruss, G. J. 1985. DNA topoisomerase I mutants: increased
heterogeneity in linking number and other replicon-dependent
changes in DNA supercoiling. J. Mol. Biol. 185:51-63.
22. Samuels, D. S., and C. F. Garon. 1993. Coumermycin A1 inhibits
growth and induces relaxation of supercoiled plasmids in Borrelia burgdorfeni, the Lyme disease agent. Antimicrob. Agents
Chemother. 37:46-50.
23. Samuels, D. S., R. T. Marconi, and C. F. Garon. Submitted for
publication.
24. Schwan, T. G., W. Burgdorfer, and C. F. Garon. 1988. Changes
in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.
Infect. Immun. 56:1831-1836.
25. Selden, R. F. 1991. Preparation and analysis of RNA, p.
4.4.4.-4.4.6. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D.
Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current
protocols in molecular biology. Greene Publishing Associates
and Wiley-Interscience, New York.
26. Simpson, W. J., W. Burgdorfer, M. E. Schrumpf, R. H.
Karstens, and T. G. Schwan. 1991. Molecular and immunological analysis of a polymorphic periplasmic protein of Borrelia
burgdorferi. J. Clin. Microbiol. 29:1940-1948.
27. Thomas, P. S. 1980. Hybridization of denatured RNA and small
DNA fragments transferred to nitrocellulose. Proc. Natl. Acad.
Sci. USA 77:5201-5205.
28. Wallich, R., C. Helmes, U. E. Schaible, Y. Lobet, S. E. Moter,
M. D. Kramer, and M. M. Simon. 1992. Evaluation of genetic

932

MARCONI ET AL.

divergence among Borrelia burgdorferi isolates using OspA, fla,
HSP60, and HSP70 gene probes. Infect. Immun. 60:4856-4866.
29. Welsh, J., C. Pretzman, D. Postic, I. Saint Girons, G. Baranton,
and M. McClelland. 1992. Genomic fingerprinting by arbitrarily
primed polymerase chain reaction resolves Borrelia burgdorfen
into three distinct phyletic groups. Int. J. Syst. Bacteriol.
42:370-377.
30. Wilske, B., V. Preac-Mursic, G. Schierz, and K. V. Busch. 1986.

J. BACTERIOL.

Immunochemical and immunological analysis of European Borrelia burgdorferi strains. Zentralbl. Bakteriol. Mikrobiol. Hyg.
Ser. A 263:92-102.
31. Wilske, B., V. Preac-Mursic, G. Schierz, R. Kuhbeck, A. G.
Barbour, and M. Kramer. 1988. Antigenic variability of Borrelia
burgdorferi. Ann. N.Y. Acad. Sci. 539:126-143.
32. Zucker, M., and P. Stiegler. 1981. Description of the method
used in RNAFOLD. Nucleic Acids Res. 9:133-148.

